Choroid plexus defects in Down syndrome brain organoids enhance neurotropism of SARS-CoV-2

  • Mohammed R. Shaker*
  • , Andrii Slonchak
  • , Bahaa Al-Mhanawi
  • , Sean D. Morrison
  • , Julian D.J. Sng
  • , Justin Cooper-White
  • , Alexander A. Khromykh
  • , Ernst J. Wolvetang*
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

13 Citations (Scopus)

Abstract

Why individuals with Down syndrome (DS) are more susceptible to SARS-CoV-2–induced neuropathology remains elusive. Choroid plexus (ChP) plays critical roles in barrier function and immune response modulation and expresses the ACE2 receptor and the chromosome 21–encoded TMPRSS2 protease, suggesting its substantial role in establishing SARS-CoV-2 infection in the brain. To explore this, we established brain organoids from DS and isogenic euploid iPSC that consist of a core of functional cortical neurons surrounded by a functional ChP-like epithelium (ChPCOs). DS-ChPCOs recapitulated abnormal DS cortical development and revealed defects in ciliogenesis and epithelial cell polarity in ChP-like epithelium. We then demonstrated that the ChP-like epithelium facilitates infection and replication of SARS-CoV-2 in cortical neurons and that this is increased in DS. Inhibiting TMPRSS2 and furin activity reduced viral replication in DS-ChPCOs to euploid levels. This model enables dissection of the role of ChP in neurotropic virus infection and euploid forebrain development and permits screening of therapeutics for SARS-CoV-2–induced neuropathogenesis.

Original languageEnglish
Article numbereadj4735
JournalScience advances
Volume10
Issue number23
DOIs
Publication statusPublished - 5 Jun 2024
Externally publishedYes

Fingerprint

Dive into the research topics of 'Choroid plexus defects in Down syndrome brain organoids enhance neurotropism of SARS-CoV-2'. Together they form a unique fingerprint.

Cite this